SCIENTURE HOLDINGS, INC. Current Liabilities
SCIENTURE HOLDINGS, INC. (SCNX) had Current Liabilities of $3.03 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-13
- 2026-06-30: Liabilities, Current $3.03M.
- 2026-03-31: Liabilities, Current $2.80M.
- 2025-12-31: Liabilities, Current $2.74M.
- 2025-09-30: Liabilities, Current $7.35M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $3.03M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $2.80M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $2.74M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $7.35M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $7.69M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $7.46M 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $7.91M 10-K · filed 2026-03-30 | |
| 2024-09-30 | $5.41M 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $2.90M 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $2.95M 10-Q · filed 2024-06-26 | |
| 2023-12-31 | $11.56M 10-K · filed 2025-03-26 | |
| 2023-09-30 | $9.09M 10-Q · filed 2024-01-16 | |
| 2023-06-30 | $4.26M 10-Q · filed 2023-08-18 | |
| 2023-03-31 | $2.55M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $2.15M 10-K · filed 2024-04-22 | |
| 2022-09-30 | $2.06M 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $2.55M 10-Q · filed 2022-07-25 | |
| 2022-03-31 | $1.60M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $926.03K 10-K · filed 2023-03-27 | |
| 2021-09-30 | $654.86K 10-Q · filed 2021-10-25 | |
| 2021-06-30 | $861.05K 10-Q · filed 2021-07-26 | |
| 2021-03-31 | $1.24M 10-Q · filed 2021-04-26 | |
| 2020-12-31 | $842.24K 10-K · filed 2022-03-28 | |
| 2020-09-30 | $534.90K 10-Q · filed 2020-10-26 | |
| 2020-06-30 | $719.83K 10-Q · filed 2020-07-27 | |
| 2020-03-31 | $950.53K 10-Q · filed 2020-05-04 | |
| 2019-12-31 | $520.82K 10-K · filed 2021-03-29 | |
| 2019-09-30 | $955.68K 10-Q · filed 2019-10-28 | |
| 2019-06-30 | $1.09M 10-Q · filed 2019-07-26 | |
| 2019-03-31 | $808.45K 10-Q · filed 2019-05-13 | |
| 2018-12-31 | $860.37K 10-K · filed 2020-03-30 | |
| 2018-06-30 | $510.70K 10-Q · filed 2018-07-27 | |
| 2018-03-31 | $469.07K 10-Q · filed 2018-04-27 | |
| 2017-12-31 | $525.36K 10-K · filed 2019-03-22 | |
| 2017-09-30 | $625.17K 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $655.97K 10-Q · filed 2017-08-04 | |
| 2017-03-31 | $1.24M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $1.47M 10-K · filed 2018-03-02 | |
| 2016-09-30 | $1.84M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $1.34M 10-Q · filed 2016-08-05 | |
| 2016-03-31 | $1.17M 10-Q · filed 2016-04-20 | |
| 2015-12-31 | $1.76M 10-K · filed 2017-03-30 | $1.05M 10-K · filed 2016-03-28 |
| 2015-09-30 | $972.30K 10-Q · filed 2015-11-02 | |
| 2015-06-30 | $1.08M 10-Q · filed 2015-07-30 | |
| 2015-03-31 | $611.61K 10-Q · filed 2015-05-04 | |
| 2014-12-31 | $553.68K 10-K · filed 2016-03-28 | |
| 2014-09-30 | $327.73K 10-Q · filed 2014-10-30 | |
| 2014-06-30 | $403.77K 10-Q · filed 2014-08-21 | |
| 2013-12-31 | $273.00K 10-K · filed 2015-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |